UNITEDHEALTH GROUP INC
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
UNH$405.12+1.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows
| For the Years Ended December 31, | |||
|---|---|---|---|
| (in millions) | 2024 | 2023 | 2022 |
| Operating activities | |||
| Net earnings | $15,242 | $23,144 | $20,639 |
| Noncash items: | |||
| Depreciation and amortization | 4,099 | 3,972 | 3,400 |
| Deferred income taxes | (296) | (245) | (673) |
| Share-based compensation | 1,018 | 1,059 | 925 |
| Loss on sale of subsidiary and subsidiaries held for sale | 8,310 | — | — |
| Gains on dispositions and other strategic transactions | (3,333) | (489) | (588) |
| Other, net | (28) | (16) | 257 |
| Net change in other operating items, net of effects from acquisitions and dispositions: | |||
| Accounts receivable | (1,437) | (3,114) | (2,523) |
| Other assets | (4,140) | (2,444) | (1,374) |
| Medical costs payable | 2,503 | 3,482 | 4,053 |
| Accounts payable and other liabilities | 2,463 | 3,516 | 1,964 |
| Unearned revenues | (197) | 203 | 126 |
| Cash flows from operating activities | 24,204 | 29,068 | 26,206 |
| Investing activities | |||
| Purchases of investments | (27,308) | (18,314) | (18,825) |
| Sales of investments | 18,514 | 7,307 | 5,907 |
| Maturities of investments | 9,319 | 9,230 | 6,081 |
| Cash paid for acquisitions and other transactions, net of cash assumed | (13,408) | (10,136) | (21,458) |
| Purchases of property, equipment and capitalized software | (3,499) | (3,386) | (2,802) |
| Loans to care providers - cyberattack | (9,033) | — | — |
| Repayments of care provider loans - cyberattack | 4,514 | — | — |
| Cash received from dispositions and other strategic transactions, net | 2,041 | 685 | 3,414 |
| Other, net | (1,667) | (960) | (793) |
| Cash flows used for investing activities | (20,527) | (15,574) | (28,476) |
| Financing activities | |||
| Common share repurchases | (9,000) | (8,000) | (7,000) |
| Cash dividends paid | (7,533) | (6,761) | (5,991) |
| Proceeds from common stock issuances | 1,846 | 1,353 | 1,253 |
| Repayments of long-term debt | (3,000) | (2,125) | (3,015) |
| (Repayments of) proceeds from short-term borrowings, net | (151) | 11 | 732 |
| Proceeds from issuance of long-term debt | 17,811 | 6,394 | 14,819 |
| Customer funds administered | (1,560) | (521) | 5,548 |
| Purchases of redeemable noncontrolling interests | (280) | (730) | (176) |
| Other, net | (1,645) | (1,150) | (1,944) |
| Cash flows (used for) from financing activities | (3,512) | (11,529) | 4,226 |
| Effect of exchange rate changes on cash and cash equivalents | (61) | 97 | 34 |
| Increase in cash and cash equivalents, including cash within businesses held for sale | 104 | 2,062 | 1,990 |
| Less: cash within businesses held for sale | (219) | — | — |
| Net (decrease) increase in cash and cash equivalents | (115) | 2,062 | 1,990 |
| Cash and cash equivalents, beginning of period | 25,427 | 23,365 | 21,375 |
| Cash and cash equivalents, end of period | $25,312 | $25,427 | $23,365 |
| Supplemental cash flow disclosures | |||
| Cash paid for interest | $3,594 | $3,035 | $1,945 |
| Cash paid for income taxes | 4,620 | 6,078 | 5,222 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.